International comparative field study of N8 evaluating factor VIII assay performance.

Abstract

Discrepancies between the one-stage clotting assay and the chromogenic method, and also among different variations of each method, have been a significant challenge for one B-domain deleted FVIII product. N8 is a B-domain truncated FVIII product developed by Novo Nordisk. The comparison of N8 and Advate(®) was performed in an international, multicentre… (More)
DOI: 10.1111/j.1365-2516.2010.02481.x